Bionano Genomics
BNGO
48 hedge funds and large institutions have $38.7M invested in Bionano Genomics in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 8 closing their positions.
585% more capital invested
Capital invested by funds: $5.65M → $38.7M (+$33M)
263% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 8
78% more funds holding
Funds holding: 27 → 48 (+21)
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$1.31M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$976K |
| 3 |
Jane Street
New York
|
+$224K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$204K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$100K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$306K |
| 2 |
SCM
Sio Capital Management
New York
|
-$174K |
| 3 |
VF
Virtu Financial
New York
|
-$164K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$50.1K |
| 5 |
JP Morgan Chase
New York
|
-$39.2K |
BNGO Hedge Fund Activity: Q4 2020 in Review
48 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2020, worth a combined $38.7M — up 585% from $5.65M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new BNGO positions and 8 closed out — a net gain of 21 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Pura Vida Investments, opening a new position worth an estimated $1.31M. The largest seller was Perkins Capital Management, exiting entirely with an estimated $306K sold.
- 48 institutional investors held Bionano Genomics (BNGO) as of Q4 2020, up from 27 in Q3 2020.
- Funds reported $38.7M of Bionano Genomics stock for Q4 2020, up 585% quarter-over-quarter.
- 29 funds opened new Bionano Genomics positions in Q4 2020 and 8 closed out, a net change of +21 holders.
- The largest Bionano Genomics buyer in Q4 2020 was Pura Vida Investments, an estimated $1.31M added.
- The largest Bionano Genomics seller in Q4 2020 was Perkins Capital Management, an estimated $306K sold.
Based on aggregated 13F filings for Q4 2020.